Dosage Optimization of Nemolizumab Using Population Pharmacokinetic and Pharmacokinetic‐Pharmacodynamic Modeling and Simulation

药代动力学 养生 药效学 医学 特应性皮炎 药理学 人口 可视模拟标度 非金属 麻醉 内科学 免疫学 环境卫生
作者
Tomohisa Saito,Satofumi Iida,Kimio Terao,Yuji Kumagai
出处
期刊:The Journal of Clinical Pharmacology [Wiley]
卷期号:57 (12): 1564-1572 被引量:7
标识
DOI:10.1002/jcph.969
摘要

Abstract Nemolizumab is a humanized anti‐interleukin‐31 receptor A monoclonal antibody for treating atopic dermatitis, and it especially improves pruritus. The objective of the simulation study was to optimize the dose regimen using a flat dose. The serum nemolizumab concentration and pruritus visual analog scale as an efficacy end point were modeled using the population analysis approach in 299 patients with atopic dermatitis who received placebo or doses between 0.1 and 3 mg/kg as a single dose once every 4 weeks or 2 mg/kg once every 8 weeks. A 1‐compartment model with first‐order absorption was employed as the pharmacokinetic model. An indirect turnover model with an inhibition component was employed as the main part of the pharmacokinetic‐pharmacodynamic model. The models well described the observations. Therefore, simulations with several dose regimens were performed to optimize the dose regimen including a flat dose. The simulated area under the concentration‐time curve at a steady state around 75 mg in the every‐4‐week regimen corresponds to that associated with the dose range of 0.5 to 2 mg/kg in the 4‐week regimen. The simulated pruritus visual analog scale also showed a similar tendency. These simulation results support dose optimization during the clinical development program of nemolizumab.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
3秒前
3秒前
量子星尘发布了新的文献求助10
3秒前
4秒前
R2L23发布了新的文献求助10
6秒前
6秒前
诚心的扬发布了新的文献求助10
7秒前
8秒前
liupc2019完成签到,获得积分10
9秒前
顾矜应助momo采纳,获得10
10秒前
周em12_发布了新的文献求助10
10秒前
11秒前
12秒前
12秒前
FashionBoy应助ZZZ采纳,获得10
13秒前
15秒前
清爽傲云发布了新的文献求助10
17秒前
17秒前
19秒前
21秒前
嗨嗨害发布了新的文献求助10
21秒前
Eileen发布了新的文献求助10
22秒前
呵呵哒发布了新的文献求助10
25秒前
清爽傲云完成签到,获得积分10
27秒前
27秒前
28秒前
momo发布了新的文献求助10
32秒前
诚心的扬关注了科研通微信公众号
33秒前
35秒前
嗨嗨害完成签到,获得积分10
36秒前
吧啦吧啦完成签到,获得积分10
36秒前
37秒前
38秒前
zero完成签到,获得积分10
39秒前
小二郎应助momo采纳,获得10
40秒前
hh完成签到 ,获得积分10
40秒前
大大完成签到 ,获得积分10
40秒前
40秒前
量子星尘发布了新的文献求助10
42秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989297
求助须知:如何正确求助?哪些是违规求助? 3531418
关于积分的说明 11253893
捐赠科研通 3270097
什么是DOI,文献DOI怎么找? 1804884
邀请新用户注册赠送积分活动 882087
科研通“疑难数据库(出版商)”最低求助积分说明 809158